DEFENCATH (TAUROLIDINE/HEPARIN) Trademark

Trademark Overview

On Thursday, June 10, 2021, a trademark application was filed for DEFENCATH (TAUROLIDINE/HEPARIN) with the United States Patent and Trademark Office. The USPTO has given the DEFENCATH (TAUROLIDINE/HEPARIN) trademark a serial number of 90766720. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 22, 2024. This trademark is owned by CorMedix Inc.. The DEFENCATH (TAUROLIDINE/HEPARIN) trademark is filed in the Pharmaceutical Products category with the following description:

Antimicrobial solution containing both taurolidine and heparin for use as a catheter lock solution
defencath (taurolidine/heparin)

General Information

Serial Number90766720
Word MarkDEFENCATH (TAUROLIDINE/HEPARIN)
Filing DateThursday, June 10, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements

Description of MarkThe mark consists of the stylized words "DEFENCATH (TAUROLIDINE/HEPARIN)" with the words "(TAUROLIDINE/HEPARIN)" positioned below the word "DEFENCATH."
Goods and ServicesAntimicrobial solution containing both taurolidine and heparin for use as a catheter lock solution
NOT AVAILABLE"(TAUROLIDINE/HEPARIN)"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 31, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCorMedix Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBerkeley Heights, NJ 07922
Party NameCorMedix Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerkeley Heights, NJ 07922

Trademark Events

Event DateEvent Description
Wednesday, March 2, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, June 14, 2021NEW APPLICATION ENTERED
Tuesday, August 31, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 1, 2022ASSIGNED TO EXAMINER
Wednesday, March 2, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, March 2, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 2, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, March 15, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, March 17, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, March 23, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 23, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, March 23, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 23, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, March 23, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 16, 2022SOU TEAS EXTENSION RECEIVED
Friday, December 16, 2022SOU EXTENSION 1 FILED
Friday, December 16, 2022SOU EXTENSION 1 GRANTED
Tuesday, December 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 12, 2023ASSIGNED TO EXAMINER
Thursday, June 15, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 15, 2023SOU EXTENSION 2 FILED
Thursday, June 15, 2023SOU EXTENSION 2 GRANTED
Saturday, June 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, December 18, 2023SOU EXTENSION 3 FILED
Monday, December 18, 2023SOU EXTENSION 3 GRANTED
Wednesday, December 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 22, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 22, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

heparin taurolidine defencath solution catheter lock both containing antimicrobial